FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Invega Hafyera (paliperidone palmitate) to expand its label for the long-acting injectable treatment of schizoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA HAFYERA (PALIPERIDONE PALMITATE)

Snippet

SUPPL AP for INVEGA HAFYERA (PALIPERIDONE PALMITATE)